Mustang Bio, Inc. (MBIO) stock
MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.01 (-2.56%)
Close on Nov 18, 2026Market cap $2.88MP/E –Yield –
Mustang Bio cash
Cash and short-term investments held at the end of each period.
Mustang Bio's cash was $15.15M at Jun 30, 2026. For fiscal 2025 it was $17.27M, up 152.5% from the year before. The highest annual figure on record is $110.62M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.27M | +152.5% |
| FY2024 | Dec 31, 2024 | $6.84M | -2.1% |
| FY2023 | Dec 31, 2023 | $6.98M | -90.9% |
| FY2022 | Dec 31, 2022 | $76.66M | -30.7% |
| FY2021 | Dec 31, 2021 | $110.62M | +12.0% |
| FY2020 | Dec 31, 2020 | $98.80M | +58.3% |
| FY2019 | Dec 31, 2019 | $62.41M | +80.5% |
| FY2018 | Dec 31, 2018 | $34.57M | -2.5% |
| FY2017 | Dec 31, 2017 | $35.48M | +29.0% |
| FY2016 | Dec 31, 2016 | $27.50M | – |
| FY2015 | Dec 31, 2015 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $15.15M | +19.7% |
| Q1 FY2026 | Mar 31, 2026 | $16.26M | +14.2% |
| Q4 FY2025 | Dec 31, 2025 | $17.27M | +152.5% |
| Q3 FY2025 | Sep 30, 2025 | $18.98M | +386.8% |
| Q2 FY2025 | Jun 30, 2025 | $12.66M | +172.6% |
| Q1 FY2025 | Mar 31, 2025 | $14.23M | +731.3% |
| Q4 FY2024 | Dec 31, 2024 | $6.84M | -2.1% |
| Q3 FY2024 | Sep 30, 2024 | $3.90M | -59.2% |
| Q2 FY2024 | Jun 30, 2024 | $4.64M | -69.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.71M | -97.1% |
| Q4 FY2023 | Dec 31, 2023 | $6.98M | -90.9% |
| Q3 FY2023 | Sep 30, 2023 | $9.56M | -89.5% |
| Q2 FY2023 | Jun 30, 2023 | $15.39M | -85.7% |
| Q1 FY2023 | Mar 31, 2023 | $58.10M | -52.5% |
| Q4 FY2022 | Dec 31, 2022 | $76.66M | -30.7% |
| Q3 FY2022 | Sep 30, 2022 | $91.36M | -24.4% |
| Q2 FY2022 | Jun 30, 2022 | $107.37M | -17.4% |
| Q1 FY2022 | Mar 31, 2022 | $122.22M | -5.5% |
| Q4 FY2021 | Dec 31, 2021 | $110.62M | +12.0% |
| Q3 FY2021 | Sep 30, 2021 | $120.88M | +60.6% |
| Q2 FY2021 | Jun 30, 2021 | $129.92M | +52.2% |
| Q1 FY2021 | Mar 31, 2021 | $129.37M | +127.7% |
| Q4 FY2020 | Dec 31, 2020 | $98.80M | +58.3% |
| Q3 FY2020 | Sep 30, 2020 | $75.25M | +2.7% |
| Q2 FY2020 | Jun 30, 2020 | $85.36M | +2.7% |
| Q1 FY2020 | Mar 31, 2020 | $56.81M | +57.4% |
| Q4 FY2019 | Dec 31, 2019 | $62.41M | +80.5% |
| Q3 FY2019 | Sep 30, 2019 | $73.29M | +289.9% |
| Q2 FY2019 | Jun 30, 2019 | $83.13M | +579.0% |
| Q1 FY2019 | Mar 31, 2019 | $36.10M | +97.8% |
| Q4 FY2018 | Dec 31, 2018 | $34.57M | -2.5% |
| Q3 FY2018 | Sep 30, 2018 | $18.80M | -43.4% |
| Q2 FY2018 | Jun 30, 2018 | $12.24M | -77.2% |
| Q1 FY2018 | Mar 31, 2018 | $18.26M | -75.7% |
| Q4 FY2017 | Dec 31, 2017 | $35.48M | +29.0% |
| Q3 FY2017 | Sep 30, 2017 | $33.21M | +198.7% |
| Q2 FY2017 | Jun 30, 2017 | $53.79M | – |
| Q1 FY2017 | Mar 31, 2017 | $75.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $27.50M | – |
| Q3 FY2016 | Sep 30, 2016 | $11.12M | – |
See a number that looks wrong?